2-BROMO-6.BETA.-FLUORO-17,21-DIHYDROXY-16.BETA.-METHYLPREGNA-1,4,9(11)-TRIENE-3,20-DIONE 21-ACETATE
UNII NUM6HP2TDN
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-bromo-6.beta.-fluoro-17,21-dihydroxy-16.beta.-methylpregna-1,4,9(11)-triene-3,20-dione 21-acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NUM6HP2TDN.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 60864-76-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H28BrFO5 PSNYSZVUCFWIID-MGQHRJHGSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-bromo-6.beta.-fluoro-17,21-dihydroxy-16.beta.-methylpregna-1,4,9(11)-triene-3,20-dione 21-acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.